You are here

OptiLIF®

The goals of an anatomy-conserving interbody fusion procedure are to:

  • Place a large implant to immediately provide structural support, restore stability and indirectly decompress the diseased segment

  • Perform the procedure through the smallest access possible to avoid trauma to the muscle and reduce compression/stretching of the neural structures to minimize the risk of neurological deficits following surgery

  • Efficiently complete the procedure to reduce the duration of time the neural structures are compressed/stretched, to mitigate the risk of neurological deficits following surgery 

 

The OptiLIF® procedure employs Spineology’s proprietary OptiMesh® Expandable Interbody Fusion System to perform interbody fusion through an access smaller than any other fusion procedure. The procedure is performed using specialized, expandable instrumentation that conserves bony anatomy and protects neural structures to provide: 

  • Enhanced recovery
  • Exceptional efficiency
  • Proven outcomes backed by FDA IDE clinical trial data  


Enhanced Recovery

The OptiLIF procedure conserves bony anatomy and protects neural structures, which means patients recover quickly,1 resulting in:

  • Short hospital stays1
  • High postoperative patient satisfaction scores1
  • Rapid return to work1
  • Reduced use of narcotics over time1

Chart showing High Patient Satisfaction

Exceptional Efficiency

Concerns about patient welfare and healthcare economics demand the use of increasingly efficient procedures. The OptiLIF procedure leads to exceptional efficiency in surgery and throughout the episode of care through the use of specialized instrumentation and techniques:

  • Tissue dilation, instead of broad dissection, and use of a facet-sparing approach speeds access to the disc space. 
  • In situ filling of OptiMesh can provide indirect decompression, or minimize the complexity of it, reducing procedural time.    
  • The minimal exposure dramatically speeds incision closure.
  • Surgeon rounding requirements are minimized due to short hospital stays.¹  

 

Proven Outcomes

Results of the Spineology Clinical Outcomes (SCOUT) study, an FDA IDE clinical trial, demonstrates the efficacy, reproducibility, and safety of the OptiLIF procedure.1

Chart showing substantial improvement in low back pain
Chart showing substantial improvement in dominant leg pain
Chart showing substantial improvement in low back function
Pie Chart showing 98 percent rate of fusion

Safety

The safety profile of this device is exceptional. There were no device-related serious adverse events or unanticipated adverse events in the SCOUT IDE study.1

The OptiLIF® procedure employs Spineology’s proprietary OptiMesh® Expandable Interbody Fusion System. To learn more about OptiMesh, click here.   

Link to OptiMesh product page

 

1. Data on file.